Literature DB >> 15192828

[Structural characterization of 5' flanking regulatory region of DNA repair gene Rad51].

Ying Yuan1, Jun Ye, Qi Dong, Shu Zheng.   

Abstract

OBJECTIVE: To clarify the regulatory elements of Rad51 gene in its 5'flanking region.
METHODS: Various constructs were obtained by cloning different DNA fragments into pGL3 reporter vector. These constructs were then introduced into osteosarcoma cell line U2-OS by calcium phosphate method for transient expression of reporter gene, and luciferase activities were measured by luciferase assay.
RESULTS: Cells transfected with pGL3 constructs containing fragment -964 to +1430 and -733 to +1430 showed high luciferase activities. Obvious elevation of luciferase activities was also observed in cells transfected with pGL3 constructs containing four shorter derivative fragments -964 to -412, -746 to -412, -651 to -412 and -536 to -412. The highest luciferase activities were measured in transfected cells with plasmids containing fragment -964 to -412, and the lowest were in transfected cells with plasmids containing fragment -536 to -412. Luciferase activities in transfected cells with plasmids containing fragment -651 to -412 were higher than that in transfected cells with plasmids containing fragment -746 to -412.
CONCLUSION: It is believable that the basic transcription-promoting element (promoter) for Rad51 gene resides between -536 to -412, and two transcription-enhancing elements (enhancer) or binding sites of positive transcription factors reside between -651 to -536 and -964 to -746, whereas one transcription-inhibiting element (silencer) or binding site of negative transcription factor may reside between -746 to -651.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192828

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  1 in total

1.  Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells.

Authors:  Vincent Fong; Marika Osterbur; Cristina Capella; Yo-El Kim; Christopher Hine; Vera Gorbunova; Andrei Seluanov; Stephen Dewhurst
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.